Piramal Pharma
In 1977, at the age of 22, Piramal started out in his own family textile business. It was founded in 1934 by his grandfather Piramal Chatrabhuj. His father, Gopikisan Piramal, died in 1979, and after 5 years he also lost her elder brother to cancer. So, his family prompting him to take over the business in 1984, Ajay Piramal was 29 years old, his father passed away, but he leaving him in charge of a flailing textile business. It is one of the longest trade union strikes. This groups entered into Glass packing in 1984 with the acquisition of Gujarat Glass, following by Ceylon glass in 1999.
Business of Piramal Groups
Piramal group is one of the India's largest diversified companies. Its business are divided into two
verticals i.e. Financial serves and pharmaceutical business and they are the Indian multinational conglomerate .
Piramal Pharma
Nicholas Laboratories was renamed to Piramal Healthcare Ltd. The company operates through 3 major segment
Contract development and manufacturing organization(CDMO),
Complex hospital generics(critical care),and
Consumer healthcare(OTC).
In 2010the Domestic formulations business was sold to About for $3.7billion and Diagnostic Services was sold to super Religare Laboratories (SRL).
The company works with a network of 6000+Hospitals.Now there office are located in 30 countries and they present in 100+world market with 30+Factory with 10000+workers.There product have 21 brands in 21 diverse nationalities and they also have 1 R&D facility. This company hold No1 position in Bio-services Industry solution in 2022 in India.
Revenue
There revenue are comes from [North Amertica41%,Europe23%,Japan4%while rest from India 22%and others(10%)].the OPM is about9%.They mostly concentrate on Western Countries.
Product list &Categories
This company product categories are in Skin care, Vitamins, Nutrition , Antacids, Analgesics, Gastro Intestinal, Oral care, pain reliefs, Woman Intimate range, Respiratory & Baby care.
Sadiron and Lacto Calamine are the well Known products from the company based on the categories.
Quality of the Product
The company has a strong focus on Quality Control with 1000+resources in the quality function and has achieved Zero Official Action Indicated (OAI)from over37 USFDA inspections and overall 293 regulatory inspections are done successfully by the company.
Fall of Piramal Pharma
This company is separate from Piramal Enterprises in 19.10.2022 at RS171.50/- from that point the share price start to fall, due to the over value IPO in NSE&BSE and this company also have the debt around 5600 crore. In November 2022 USFDA (US Food and drugs Associate) start raid in the US pharma production plant.
Rise of Piramal Pharma
The USFDA raid came to end in May52023with the positive result. This lead the share price raise into10%.
Future of Piramal Pharma
This company share price can reach Rs200/-in2025 due to the rasie of pharma sector. This company are mostly located in Europe &US. Now there OPM value is under9% but the competitor have more future prosperity to growth in revenue. They also reduce the pharma Debt from the past2years.This indicate the company have future growth.
Comments
Post a Comment